https://doi.org/10.4081/hmr.v3i3.556

Alterations of microenvironment in multiple myeloma patients: interactions between myeloma cells and osteoprogenitor cells

Vol. 3 No. 3: 7th Meeting New Insights in Hematology Venice, Italy, 26-29 April 2009
Published: June 12, 2009
Abstract Views: 189
PDF: 249
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

N Giuliani
support@pagepress.org
V Rizzoli
Multiple myeloma (MM) is a plasmacell malignancy characterized by the tight relationship with the bone marrow (BM) microenvironment that has a pivotal role in the regulation of myeloma cell growth and survival through the production of several growth factors and the increase of BM angiogenesis. Bone microenvironment cells as osteoclasts and osteoblasts also support the survival of MM cells. The study of the alterations of the microenvironment and that of the interactions between MM and microenviroment cells has leaded to identify new therapeutics targets in MM patients and to develop new drugs targeting both MM cells and the microenvironment including endothelial cells, T lymphocytes osteoclast and osteoblast. Particularly in the last years we and other authors have studied the alterations occurring in the bone cells in MM patients, the biological mechanisms involved in the interactions between MM cells and osteoprogenitor/osteoblastic cells and the potential role of osteoblastic cells in the antitumoral effect of the new drugs.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Giuliani, N., & Rizzoli, V. (2009). Alterations of microenvironment in multiple myeloma patients: interactions between myeloma cells and osteoprogenitor cells. Hematology Meeting Reports (formerly Haematologica Reports), 3(3). https://doi.org/10.4081/hmr.v3i3.556
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).